5 programs scored · 2 flagged high-risk · calibrated on published base rates
| program | phase | success | verdict | grounded evidence |
|---|---|---|---|---|
| EZH2 · lymphoma | phase_2 | 19% | LIKELY FAILURE — spot it now | genetic no · druggable yes · refs 6 |
| CFTR · lymphoma | phase_2 | 19% | LIKELY FAILURE — spot it now | genetic no · druggable yes · refs 6 |
| CFTR · cystic fibrosis | phase_2 | 38% | PROCEED WITH CARE | genetic yes · druggable yes · refs 6 |
| BCL2 · lymphoma | phase_3 | 63% | SUPPORTED | genetic no · druggable yes · refs 6 |
| HBB · sickle cell anemia | phase_3 | 90% | SUPPORTED | genetic yes · druggable yes · refs 6 |